1 tracked superinvestor hold VAXCYTE INC (PCVX), worth $46M combined, led by Seth Klarman. Smart money is accumulating PCVX as of the latest 13F filings.
Current price
$59.83
+60.6%
1Y
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging…
Market cap
$8.2B
P/E
-10.11
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$89
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$46M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating PCVX: 1 funds added or opened versus 0 trimming. 1 opened a brand-new position.
VAXCYTE INC (PCVX) is held by 1 tracked funds worth $46M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Seth Klarman at 0.9% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
This quarter 1 fund opened a brand-new position (Seth Klarman), with 0 adding and 0 trimming — a net accumulation signal.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| New buy | 0.9% | $46M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own PCVX?
1 tracked funds hold VAXCYTE INC (PCVX), the largest being Seth Klarman (Baupost Group) at 0.9% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling PCVX?
In the most recent 13F quarter, 1 tracked fund added or opened PCVX and 0 trimmed it, including 1 brand-new position.
How much PCVX do tracked funds hold?
Combined disclosed long exposure to PCVX across tracked superinvestors is $46M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.